Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1568523

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1568523

eConsent in Healthcare Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 5350
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The Global eConsent in Healthcare Market is poised to grow at 10.6% CAGR from 2024 to 2032, driven by the increasing digitization of healthcare systems and the need for efficient, compliant patient consent processes. eConsent technology empowers healthcare providers to electronically obtain and manage patient consents, boosting patient engagement and ensuring adherence to regulations.

The market trends are driven by technological innovations, a rising emphasis on patient-centric care, and the push to streamline consent workflows. Moreover, the desire to simplify workflows and lessen administrative burdens in clinical trials and treatment consents is accelerating the technology's adoption.

The eConsent in Healthcare Industry is segmented based on deployment mode, application, workflow integration, user interface, end-use, and region.

Throughout the forecast period, the on-premises deployment mode of eConsent solutions is poised for significant growth. Healthcare organizations favor on-premises deployments for enhanced control over data security and adherence to regulatory standards. Such deployments enable organizations to house data within their infrastructure, offering heightened customization and seamless integration with current systems.

Concerns surrounding data privacy and security, coupled with the imperative to meet stringent healthcare regulations, are propelling the preference for on-premises eConsent solutions. This inclination is especially evident among large healthcare institutions and research entities managing sensitive patient information.

By 2032, treatment consent applications are projected to command a notable portion of the eConsent market. These applications play a pivotal role in ensuring patients grasp the risks, benefits, and alternatives of medical treatments prior to consenting. eConsent solutions tailored for treatment consent bolster transparency, enhance patient engagement, and ensure documentation accuracy, all vital for informed decision-making.

With healthcare providers increasingly prioritizing patient-centric care, there's a surging demand for digital tools that streamline and ensure compliance in consent processes. Furthermore, the rising incidence of chronic diseases necessitating continuous patient monitoring and treatment amplifies the demand for eConsent solutions in treatment consent applications.

From 2024 to 2032, Europe is set to make notable strides in Global eConsent in healthcare industry. This growth is attributed to the region's strong healthcare infrastructure, hefty investments in digital health technologies, and rigorous regulatory frameworks. The European Union's focus on data protection and patient rights, especially with the rollout of the General Data Protection Regulation (GDPR), is catalyzing the shift towards secure and compliant eConsent solutions.

Moreover, the region's commitment to enhancing patient outcomes, coupled with the rising adoption of telemedicine and remote patient monitoring, is propelling the market's growth. Further strengthening Europe's stance as a dominant player in the eConsent healthcare market are government initiatives championing digital health and the presence of top-tier healthcare technology providers.

Product Code: 10379

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Shift towards digital health records and electronic processes
      • 3.2.1.2 Rise of telehealth and remote care services
      • 3.2.1.3 Increasing awareness among patients
      • 3.2.1.4 Expansion and globalization of clinical trials
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Initial setup and integration costs for eConsent systems
      • 3.2.2.2 Risk of data breaches and cyberattacks
  • 3.3 Growth potential analysis
  • 3.4 Technology landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 GAP analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Deployment Mode, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Cloud-based
  • 5.3 On-premises

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Clinical trials
  • 6.3 Treatment consent
  • 6.4 Telemedicine

Chapter 7 Market Estimates and Forecast, By Workflow Integration, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Integrated solutions
  • 7.3 Standalone solutions

Chapter 8 Market Estimates and Forecast, By User Interface, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Web-based platforms
  • 8.3 Mobile applications

Chapter 9 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Clinical research organizations
  • 9.3 Hospitals and clinics
  • 9.4 Pharmaceutical and biotech companies
  • 9.5 Other end-users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
    • 10.3.7 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
    • 10.4.6 Rest of Asia Pacific
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Argentina
    • 10.5.4 Rest of Latin America
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE
    • 10.6.4 Rest of Middle East and Africa

Chapter 11 Company Profiles

  • 11.1 Advarra
  • 11.2 Calysta EM
  • 11.3 Castor
  • 11.4 Climedo Health GmbH
  • 11.5 Clinical ink
  • 11.6 Concentric Health Ltd
  • 11.7 Epic Communications
  • 11.8 EvidentIQ Group GmbH
  • 11.9 Florence Healthcare
  • 11.10 Interlace Health
  • 11.11 IQVIA
  • 11.12 Obvio Health USA, Inc.
  • 11.13 Signant Health
  • 11.14 Suvoda LLC
  • 11.15 Veeva Systems
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!